BIOLASE

BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Lake Forest, CA.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

BIOLASE reports strong Q1 performance, eyes profitability through market growth

BIOLASE's Q1 2024 earnings reflect a robust performance with growth in sales and improved financial metrics. The company's strategic focus on accelerating dental laser adoption and operational enhancements position it well for future success. While challenges exist in achieving profitability, BIOLASE's opportunities in the dental market and growth initiatives offer a positive outlook.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1984 and is headquartered in Lake Forest, CA.

LAKE FOREST, Calif. , June 27, 2022 /PRNewswire/ --  BIOLASE , Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has partnered with Project HOME , an organization that provides dental services to patients from their first birthday to adulthood.

BIOLASE ANNOUNCES SUPPORT FOR PROJECT HOME

The industry leading webinar series adds new dates and content for multi-specialty support LAKE FOREST, Calif. , June 21, 2022 /PRNewswire/ -- BIOLASE, Inc.  (NASDAQ: BIOL), the global leader in dental lasers, announced today the extension of its digital learning webinar series "Advancing Dentistry" for remote dental training and continuing education ("CE") credits through the third quarter of 2022.

BIOLASE ANNOUNCES ADVANCING DENTISTRY WEBINARS FOR Q3 2022

The podcast series includes engaging interviews with leading industry experts, specialists, general dentists and hygienists that share the benefits of laser technology in dentistry LAKE FOREST, Calif. , June 13, 2022 /PRNewswire/ -- BIOLASE, Inc.

BIOLASE ANNOUNCES ADVANCING DENTISTRY PODCAST

Event will focus on optimizing integration of lasers into clinical practice with recognized leaders from all dental specialties and academia FOOTHILL RANCH, Calif. , June 9, 2022 /PRNewswire/ --  BIOLASE, Inc.  (NASDAQ: BIOL), the global leader in dental lasers is proud to host its first annual meeting of leading dental laser experts on June 10, 2022 and June 11, 2022 at the Avenue of the Arts in Costa Mesa, CA.

BIOLASE ANNOUNCES INAUGURAL CLINICAL EXCELLENCE FORUM

LAKE FOREST, Calif. , June 6, 2022 /PRNewswire/ -- To further accelerate the adoption of lasers as the gold standard of care in dentistry, BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, has entered into a lease agreement in Foothill Ranch in Lake Forest, California to expand its training operations footprint and establish its first ever dental office, or Model Dental Office ("MDO").

BIOLASE SIGNS LEASE TO EXPAND TRAINING AND EDUCATION INITIATIVES

LAKE FOREST, Calif. , June 2, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it will be presenting at the 2022 LD Micro Invitational, a prominent three-day investor conference, at the Four Seasons Hotel Westlake Village on Wednesday, June 8, 2022 at 3:30 PM PST / 6:30 PM EST.

BIOLASE TO PRESENT AT LD MICRO INVITATIONAL INVESTOR CONFERENCE ON JUNE 8, 2022

Multi-dimensional team of leading specialists, general dentists and hygienists will support the rapid adoption of BIOLASE dental lasers in practices across North America LAKE FOREST, Calif. , June 1, 2022 /PRNewswire/ -- BIOLASE, Inc.

BIOLASE CREATES FIRST-OF-ITS-KIND CLINICAL INTEGRATION TEAM

"CEO on the Go" John Beaver visits with customers and future customers, gathering feedback and sharing BIOLASE's commitment to minimally-invasive dentistry for dentists & patients LAKE FOREST, Calif. , May 24, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, shared today that CEO John Beaver will continue his global "CEO on the Go" customer visit initiative throughout the year.

BIOLASE CEO SHARES VISION FOR KINDLER, GENTLER DENTISTRY WITH CUSTOMERS AROUND THE WORLD

FOOTHILL RANCH, Calif. , May 16, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has been invited to present at the Spring Into Action Best Ideas Virtual Investor Conference being held May 17-20, 2022.

BIOLASE TO PARTICIPATE IN THE SPRING INTO ACTION BEST IDEAS VIRTUAL INVESTOR CONFERENCE MAY 17-20, 2022

FOOTHILL RANCH, Calif. , May 16, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has received notice from the Nasdaq Stock Market LLC (Nasdaq) on May 13, 2022 informing BIOLASE that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Rule") for continued listing on The Nasdaq Capital Market.

BIOLASE REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

BIOLASE, Inc. (NASDAQ:BIOL ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Todd Kehrli - Investor Relations, EVC Group John Beaver - President and Chief Executive Officer Jennifer Bright - Vice President of Finance Conference Call Participants Bruce Jackson - The Benchmark Company Matt Bullock - Maxim Group Kyle Bauser - Lake Street Operator Good day, and welcome to the BIOLASE First Quarter 2022 Results Conference Call. All participants will be in a listen-only mode.

BIOLASE, Inc. (BIOL) CEO John Beaver on Q1 2022 Results - Earnings Call Transcript

LAKE FOREST, Calif. , May 12, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the first quarter ended March 31, 2022.

BIOLASE MAINTAINS GROWTH MOMENTUM AS FIRST QUARTER REVENUE INCREASED 25% YEAR OVER YEAR

FOOTHILL RANCH, Calif. , May 9, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that Kenneth P.

BIOLASE STRENGTHENS ITS BOARD OF DIRECTORS WITH ADDITION OF SEASONED HEALTHCARE EXECUTIVE

FOOTHILL RANCH, Calif. , May 4, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2022 financial and operating results on Thursday, May 12, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m.

BIOLASE, Inc to Report First Quarter 2022 Results on May 12, 2022

COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON APRIL 29, 2022 LAKE FOREST, Calif., April 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), today announced that it held its annual meeting of stockholders on April 28, 2022 where the Company's stockholders granted the Board of Directors the discretion to effect a reverse stock split of the Company's common stock at a ratio between 1-to-2 and 1-to-25.

BIOLASE ANNOUNCES 1-FOR-25 REVERSE STOCK SPLIT

FOOTHILL RANCH, Calif. , March 23, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that President and CEO, John Beaver, has been invited to participate in the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28th - 30th.

BIOLASE TO PARTICIPATE IN MAXIM GROUP'S 2022 VIRTUAL GROWTH CONFERENCE HOSTED BY M-VEST ON MARCH 28TH - 30TH

BIOLASE, Inc. (BIOL) CEO John Beaver on Q4 2021 Results - Earnings Call Transcript

Robust Balance Sheet to Execute Growth Strategies in 2022 Full Year 2022 Revenue Growth Outlook +10% LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ended December 31, 2021.

BIOLASE REPORTS CONTINUED GROWTH FOR FOURTH QUARTER AND FULL YEAR 2021

FOOTHILL RANCH, Calif. , March 3, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release fourth quarter and full-year 2021 financial and operating results on Thursday, March 17, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m.

BIOLASE to Report Fourth Quarter and Full Year 2021 Results on March 17, 2022

FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly-designated Series G Preferred Stock, par value $0.001 per share, for each outstanding share of BIOLASE common stock held of record as of 5:00 p.m.

BIOLASE Announces Distribution of Series G Preferred Stock to Holders of Its Common Stock

IRVINE, Calif. , Jan. 20, 2022 /PRNewswire/ -- BIOLASE, Inc.  (NASDAQ:  BIOL ), the global leader in dental lasers, today announced a continuation of their collaboration with  BMW Performance Center West  (BMW PCW) at The Thermal Club near Palm Springs, to offer dentists the unique opportunity to experience two state-of-the-art pieces of technology; the Waterlase dental laser and BMW award-winning vehicles.

BIOLASE Announces Continuation of Exclusive Collaboration with BMW Performance Center West (BMW PCW) and Winner of BMW Sweepstakes

Company releases very strong preliminary Q4 top-line numbers with revenues now eclipsing pre-COVID numbers. Despite solid execution, shares have retreated by 80% from recent highs as investors remain wary of ongoing cash usage and a potential reverse stock split to regain Nasdaq listing compliance.

BIOLASE - Speculative Buy After Strong Preliminary Q4 Results

FOOTHILL RANCH, Calif. , Jan. 10, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced preliminary 2021 fourth quarter revenue results that are significantly above fourth quarter revenue for both 2020 and pre-COVID 2019.

BIOLASE ANNOUNCES POSTIVE PRELIMINARY REVENUE RESULTS FOR 2021 FOURTH QUARTER; ENTERS 2022 WITH SIGNIFICANT MOMENTUM

FOOTHILL RANCH, Calif., Jan. 6, 2022 /PRNewswire/ --  BIOLASE, Inc.  (NASDAQ: BIOL), the global leader in dental lasers, and  EdgeEndo , a global leader in commercializing endodontic products, announced today the FDA 510(k) clearance of the Ed gePRO  system for endodontists seeking a more effective cleaning and disinfection alternative within root canal procedures.

BIOLASE and EdgeEndo Announce FDA 510(k) Clearance of New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists

FOOTHILL RANCH, Calif., Jan. 5, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it will participate in the H.C.

News for BIOLASE Stock (BIOL)